New drug duo shows promise against tough liver cancer
NCT ID NCT04487067
First seen Nov 01, 2025 · Last updated Apr 09, 2026 · Updated 22 times
Summary
This study tested a combination of two existing drugs (atezolizumab and bevacizumab) for people with advanced liver cancer that cannot be removed by surgery. The trial involved 152 patients who had not received any previous drug treatment for their cancer. Researchers wanted to see how safe and effective this drug combination would be in controlling the disease and extending survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, HEPATOCELLULAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O. S. Orsola Malpighi
Bologna, Emilia-Romagna, 40138, Italy
-
A.O. Universitaria S. Martino Di Genova
Genoa, Liguria, 16132, Italy
-
A.O.U Careggi
Florence, Tuscany, 50124, Italy
-
A.O.U. Cagliari-P.O. Monserrato
Cagliari, Sardinia, 09100, Italy
-
A.O.U. Policlinico Paolo Giaccone
Palermo, Sicily, 90127, Italy
-
Arcispedale Santa Maria Nuova
Reggio Emilia, Emilia-Romagna, 42100, Italy
-
Azienda Osp Uni Seconda Università Degli Studi Di Napoli
Naples, Campania, 80131, Italy
-
Azienda Ospedaliera Di Rilievo Nazionale E Di Alta Specializzazione Garibaldi
Palermo, Sicily, 90127, Italy
-
Azienda Ospedaliera Ordine Mauriziano di Torino
Turin, Piedmont, 10128, Italy
-
Azienda Ospedaliera San Camillo Forlanini
Rome, Lazio, 00151, Italy
-
Azlenda Ospendaliero-Universitaria Pisana
Pisa, Tuscany, 56100, Italy
-
Clinica Oncologica-Ospedali Riuniti Ancona
Torrette, Tuscany, 60020, Italy
-
Fondazione IRCCS Ospedale Maggiore Policlinico
Milan, Lombardy, 20122, Italy
-
Fondazione Pascale
Naples, Campania, 80100, Italy
-
IOV - Istituto Oncologico Veneto - IRCCS
Padova, Veneto, 35128, Italy
-
IRCCS Ospedale Casa Sollievo Della Sofferenza
San Giovanni Rotondo, Apulia, 71013, Italy
-
Istituto Clinico Humanitas
Rozzano, Lombardy, 20089, Italy
-
Istituto Nazionale Dei Tumori
Milan, Lombardy, 20133, Italy
-
Ospedale del Mare
Naples, Campania, 80147, Italy
-
Ospedali Riuniti - Bergamo
Bergamo, Lombardy, 24128, Italy
-
Policlinico Universitario Agostino Gemelli
Rome, Lazio, 00168, Italy
Conditions
Explore the condition pages connected to this study.